Medicina
Departamento
University of Wisconsin–Madison
Madison, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Wisconsin–Madison (18)
2022
-
Performance of the American Heart Association/American College of Cardiology/Heart Rhythm Society versus European Society of Cardiology guideline criteria for hospital admission of patients with syncope
Heart Rhythm, Vol. 19, Núm. 10, pp. 1712-1722
-
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Blood, Vol. 140, Núm. 5, pp. 419-437
2018
2015
-
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773
2014
-
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey
Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 5, pp. 666-672
2011
-
Chronic kidney disease stage progression in liver transplant recipients
Clinical Journal of the American Society of Nephrology, Vol. 6, Núm. 8, pp. 1851-1857
-
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Journal of Clinical Oncology, Vol. 29, Núm. 18, pp. 2598-2607
-
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Blood
2009
-
Pulmonary zygomycosis in solid organ transplant recipients in the current era
American Journal of Transplantation, Vol. 9, Núm. 9, pp. 2166-2171
-
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome
Journal of Infectious Diseases, Vol. 200, Núm. 6, pp. 1002-1011
2008
-
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation
Journal of the American Society of Nephrology, Vol. 19, Núm. 4, pp. 812-824
-
C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts
Transplantation, Vol. 86, Núm. 12, pp. 1849-1856
-
CD4+CD25+FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with campath-1H
American Journal of Transplantation, Vol. 8, Núm. 4, pp. 793-802
2007
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials
Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343
2006
-
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study
Transplantation, Vol. 81, Núm. 3, pp. 320-326
-
Late-onset invasive aspergillosis in organ transplant recipients in the current era
Medical Mycology, Vol. 44, Núm. 5, pp. 445-449
2005
-
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)
Journal of Cardiac Failure, Vol. 11, Núm. 4, pp. 260-269